In-depth immune and molecular profiling of melanoma patients receiving adoptive T-cell therapy reveals biomarkers of efficacy in ATATIL study.
Angela Orcurto,Johanna Chiffelle,Eleonora Ghisoni,David Barras,Isaac Crespo,Blanca Navarro Rodrigo,Maria Ochoa de Olza,Martina Imbimbo,Sylvie Rusakiewicz,Stephanie Tissot,Philippe O. Gannon,Urania Dafni,Stefan Zimmermann,Lana E. Kandalaft,Olivier Michielin,Michal Bassani-Sternberg,Denarda Dangaj,Lionel Trueb, Alexander Harari,George Coukos JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
